October 18, 2023
Via: ArsTechnicaAfter raising the price of COVID-19 vaccines more than fourfold this year, Pfizer CEO Albert Bourla told investors Monday that the company will also likely hike the price of its lifesaving COVID-19 antiviral treatment, Paxlovid, raising further concern about access […]
December 11, 2023
December 11, 2023